Bringing Quality to Life

Aureum offer a complete outsourcing solution for the manufacturing of medicinal cannabis extracts. Our services cover all aspects of contract manufacturing, from product formulation and production to primary and secondary packaging.

Based in Denmark, Aureum is a European contract manufacturing organization, specialized in manufacturing of medicinal cannabis extracts.

icon

We operate under the Danish legal framework for medicinal cannabis in compliance with Good Manufacturing Practices (GMP).

icon

We have all the expertise it takesto formulate and manufacture the product that your organization requires.

icon

Our services are divided into three categories while the solutions are tailormade for your specific purposes.

Contract Manufacturing of Medicinal Cannabis Extracts

Contract Processing

Aureum offers contract processing of medicinal cannabis flower to licensed producers. As your outsourcing partner we can extract and process raw material to meet your specific product requirements. Our services include all aspects of contract manufacturing, from development of analytical methods, formulation, and processing to primary and secondary packaging.

White Label

Our white label service is a one-stop-shop solution, covering all aspects from sourcing of raw material, product formulation, processing, and packaging. As your outsourcing partner, we are supporting each step from prototype development and product registration to pilot batches and large-scale manufacturing.

Active Pharmaceutical Ingredient

We offer consistent supply of extracted cannabinoids in any quantity and format required. Whether it is for R&D purposes or further downstream processing we can tailor the solution to meet your organizations specific requirements.

What We Do

Aureum A/S is a Danish-based contract manufacturing organization founded in December 2018.

We provide contract processing services, white label products and API to the medicinal cannabis industry.

Aureum is licensed under the Danish Development Scheme and expects to be operational under the Danish Pilot Program primo 2021. On January 1st 2018, the Danish medicinal cannabis pilot program entered into force, allowing for a special development scheme for the cultivation and manufacturing of medicinal cannabis.

The purpose of the program is to supply medicinal cannabis intermediate products to patients and to create a Danish export market. Learn more about the development scheme and pilot program in Denmark.

Who We Are

Management

Peter Emil Sigetty

Co-founder & CEO
M.S.C in Economics & Business Administration

Inge-Lise Hassing

Production Manager
M.S.c in Pharmacy

Henriette Dahlgaard

Head of Quality
M.S.c in Chemical Engineering

Board of Directors

Joel Sherlock

Chairman
Co-founder / Chairman at Vitalis Extraction Technology Inc.

Nelson C. Cury

Board Member
Managing Partner, GreenField Global Opportunities Fund

Mike S. Hansen

Board Member
Partner at Mortgang Lawyers

Farzad Jahanshahi

Board Member
CEO Medican A/S

William Muecke

Board Member
Co-founding managing member, Artemis Growth Partner